应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SYRE SPYRE THERAPEUTICS INC
盘后交易 09-26 19:04:33 EDT
29.06
+1.35
+4.87%
盘后
29.06
+0.00
0.00%
16:11 EDT
最高
30.11
最低
27.90
成交量
229.73万
今开
28.22
昨收
27.71
日振幅
7.98%
总市值
14.76亿
流通市值
10.26亿
总股本
5,079万
成交额
6,555万
换手率
6.51%
流通股本
3,531万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Spyre Therapeutics, Inc.盘中异动 股价大跌5.22%
市场透视 · 09-24 21:33
Spyre Therapeutics, Inc.盘中异动 股价大跌5.22%
Spyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报30.42美元
市场透视 · 09-20
Spyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报30.42美元
Spyre Therapeutics Inc 预计每股亏损 95 美分 - 财报前瞻
Reuters · 08-07
Spyre Therapeutics Inc 预计每股亏损 95 美分 - 财报前瞻
Spyre Therapeutics Inc 预计每股亏损 1.17 美元 - 财报前瞻
Reuters · 05-08
Spyre Therapeutics Inc 预计每股亏损 1.17 美元 - 财报前瞻
Spyre Therapeutics(SYRE.US)获Baird首次覆盖,给予优于大市评级, 目标价50.00美元。
智通财经 · 05-02
Spyre Therapeutics(SYRE.US)获Baird首次覆盖,给予优于大市评级, 目标价50.00美元。
加载更多
公司概况
公司名称:
SPYRE THERAPEUTICS INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Spyre Therapeutics, Inc.于2013年12月16日从特拉华州有限责任公司转换而来。该公司是一家生物技术公司,旨在通过结合同类最佳的抗体工程、合理的治疗组合以及用于患者选择的精准医疗方法,创造下一代炎症性肠病(IBD)产品。Spyre的产品线包括针对α4β7、TL1A和IL-23的延长半衰期抗体。
发行价格:
--
{"stockData":{"symbol":"SYRE","market":"US","secType":"STK","nameCN":"SPYRE THERAPEUTICS INC","latestPrice":29.06,"timestamp":1727380800000,"preClose":27.71,"halted":0,"volume":2297310,"hourTrading":{"tag":"盘后","latestPrice":29.06,"preClose":29.06,"latestTime":"16:11 EDT","volume":1470932,"amount":42745283.92,"timestamp":1727381499373},"delay":0,"floatShares":35314911,"shares":50792374,"eps":-7.305994,"marketStatus":"盘后交易","marketStatusCode":4,"change":1.35,"latestTime":"09-26 19:04:33 EDT","open":28.22,"high":30.11,"low":27.9,"amount":65547652.9785,"amplitude":0.079755,"askPrice":32.19,"askSize":30,"bidPrice":25.98,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-7.305994,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1727395200000},"adr":0,"listingDate":1460001600000,"adjPreClose":27.71,"preHourTrading":{"tag":"盘前","latestPrice":28.32,"preClose":27.71,"latestTime":"09:29 EDT","volume":176,"amount":4984.593152,"timestamp":1727357370095},"postHourTrading":{"tag":"盘后","latestPrice":29.06,"preClose":29.06,"latestTime":"16:11 EDT","volume":1470932,"amount":42745283.92,"timestamp":1727381499373},"volumeRatio":2.791143,"impliedVol":0.9178,"impliedVolPercentile":0.7563},"requestUrl":"/m/hq/s/SYRE","defaultTab":"news","newsList":[{"id":"2470401458","title":"Spyre Therapeutics, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470401458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470401458?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:33","pubTimestamp":1727184784,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时33分,Spyre Therapeutics, Inc.股票出现异动,股价快速跳水5.22%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.78%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242133049f132428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242133049f132428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2468689262","title":"Spyre Therapeutics, Inc.盘中异动 下午盘股价大涨5.04%报30.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468689262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468689262?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:31","pubTimestamp":1726770716,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时31分,Spyre Therapeutics, Inc.股票出现异动,股价大幅拉升5.04%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.14%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920023156a1db3a3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920023156a1db3a3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SYRE"],"gpt_icon":0},{"id":"2457114825","title":"Spyre Therapeutics Inc 预计每股亏损 95 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457114825","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457114825?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:31","pubTimestamp":1723044684,"startTime":"0","endTime":"0","summary":" * Spyre Therapeutics Inc 预计将在8月9日公布截至2024年6月30日的业绩() 时显示季度收入增长 * 根据LSEG的数据,5位分析师的平均预期显示,这家总部位于马萨诸塞州沃尔瑟姆的公司的营收预计将从一年前的68.8万美元增长481.4%,达到400万美元。* LSEG 分析师对 Spyre Therapeutics Inc 的平均预期是每股亏损 95 美分。* 华尔街对 Spyre Therapeutics Inc 的 12 个月目标价中位数为 50.00 美元,高于其最新收盘价 26.04 美元。8月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","SYRE"],"gpt_icon":0},{"id":"2433780220","title":"Spyre Therapeutics Inc 预计每股亏损 1.17 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433780220","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433780220?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:01","pubTimestamp":1715101283,"startTime":"0","endTime":"0","summary":" * Spyre Therapeutics Inc 预计在5月9日公布截至2024年3月31日的业绩报告时,季度收入将出现下降(预计) * * LSEG分析师对Spyre Therapeutics Inc的平均预期是每股亏损1.17美元。* 华尔街对 Spyre Therapeutics Inc 的 12 个月目标价中位数为 50.00 美元,高于其上次收盘价 35.77 美元。5月7日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","SYRE"],"gpt_icon":0},{"id":"2432629359","title":"Spyre Therapeutics(SYRE.US)获Baird首次覆盖,给予优于大市评级, 目标价50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432629359","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432629359?lang=zh_cn&edition=full","pubTime":"2024-05-02 17:06","pubTimestamp":1714640790,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SYRE","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.spyre.com","stockEarnings":[{"period":"1week","weight":-0.0432},{"period":"1month","weight":0.0267},{"period":"3month","weight":0.2202},{"period":"6month","weight":-0.2694},{"period":"1year","weight":1.4457},{"period":"ytd","weight":0.2876}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":0.0165},{"period":"3month","weight":0.0433},{"period":"6month","weight":0.0898},{"period":"1year","weight":0.3385},{"period":"ytd","weight":0.1993}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spyre Therapeutics, Inc.于2013年12月16日从特拉华州有限责任公司转换而来。该公司是一家生物技术公司,旨在通过结合同类最佳的抗体工程、合理的治疗组合以及用于患者选择的精准医疗方法,创造下一代炎症性肠病(IBD)产品。Spyre的产品线包括针对α4β7、TL1A和IL-23的延长半衰期抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.048662},{"month":2,"riseRate":0.5,"avgChangeRate":0.010915},{"month":3,"riseRate":0.5,"avgChangeRate":0.028824},{"month":4,"riseRate":0.125,"avgChangeRate":-0.064934},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.065599},{"month":6,"riseRate":0.444444,"avgChangeRate":0.134669},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.017321},{"month":8,"riseRate":0.888889,"avgChangeRate":0.124194},{"month":9,"riseRate":0.444444,"avgChangeRate":0.00996},{"month":10,"riseRate":0.25,"avgChangeRate":0.066053},{"month":11,"riseRate":0.375,"avgChangeRate":-0.006246},{"month":12,"riseRate":0.375,"avgChangeRate":-0.013127}],"exchange":"NASDAQ","name":"SPYRE THERAPEUTICS INC","nameEN":"SPYRE THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.0","shortVersion":"4.28.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SPYRE THERAPEUTICS INC(SYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SPYRE THERAPEUTICS INC(SYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SPYRE THERAPEUTICS INC,SYRE,SPYRE THERAPEUTICS INC股票,SPYRE THERAPEUTICS INC股票老虎,SPYRE THERAPEUTICS INC股票老虎国际,SPYRE THERAPEUTICS INC行情,SPYRE THERAPEUTICS INC股票行情,SPYRE THERAPEUTICS INC股价,SPYRE THERAPEUTICS INC股市,SPYRE THERAPEUTICS INC股票价格,SPYRE THERAPEUTICS INC股票交易,SPYRE THERAPEUTICS INC股票购买,SPYRE THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SPYRE THERAPEUTICS INC(SYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SPYRE THERAPEUTICS INC(SYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}